OOIR: Observatory of International Research

Papers

(The TQCC of Southern African Journal of HIV Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis	35
Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020	18
HIV infection in Eastern and Southern Africa: Highest burden, largest challenges, greatest potential	18
Ten years of nurse-initiated antiretroviral treatment in South Africa: A narrative review of enablers and barriers	14
World AIDS Day 2020: Reflections on global and South African progress and continuing challenges	13
COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region	11
Profile of presentation of HIV-positive patients to an emergency department in Johannesburg, South Africa	9
Establishing targets for advanced HIV disease: A call to action	9
Ocular manifestations of people living with HIV in Tunisia	8
Uptake of the Ithaka mobile application in Johannesburg, South Africa, for human immunodeficiency virus self-testing result reporting	8
Undisclosed exposure to antiretrovirals prior to treatment initiation: An exploratory analysis	8
Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa	7
Geographical variation in HIV testing in South Africa: Evidence from the 2017 national household HIV survey	7
Association between socio-economic factors and HIV self-testing knowledge amongst South African women	7
Earlier antiretroviral initiation is independently associated with better arterial stiffness in children living with perinatally acquired HIV with sustained viral suppression in Mozambique	6
Breaking the unbreakable: A paediatric case of dolutegravir resistance from KwaZulu-Natal	6
Access to HIV services and viral load suppression among children during the 90-90-90 strategy implementation in South Africa: A time series analysis	6
A trio of infectious diseases and pulmonary embolism: A developing world’s reality	5
Be legally wise: When is parental consent required for adolescents’ access to pre-exposure prophylaxis (PrEP)?	5
Southern African HIV Clinicians Society guidelines for harm reduction	5
Factors associated with viral suppression among adolescents on antiretroviral therapy in Free State province, South Africa	5
Depression, sleep quality and condom use amongst Iranian people living with human immunodeficiency virus	5
Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians	5
Low-level viraemia despite emergence of dolutegravir-resistant variants	5
Immune activation and arterial stiffness in lean adults with HIV on antiretroviral therapy	5

Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women	5
Evaluation of an SMS-based mHealth intervention to enhance early infant diagnosis follow-up testing and assessment of postnatal prophylaxis	4
Optimised paediatric antiretroviral treatment to achieve the 95-95-95 goals	4
Arterial stiffness is associated with oxidative stress and endothelial activation among persons with treated HIV in Zambia	4
COVID-19 and HIV viral load suppression in children and adolescents in Durban, South Africa	4
Five years after Treat All implementation: Botswana’s HIV response and future directions in the era of COVID-19	4
Weight gain on dolutegravir: Association is not the same as causation	4
Ethically acceptable consent approaches to adolescent research in South Africa	3
Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study	3
The prevalence and spectrum of mucocutaneous disease in South African people living with HIV and accessing care at a district-level hospital	3
Looking back at paediatric HIV treatment in South Africa. My, how we have grown!	3
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV	3
Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa	3
Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate	3
Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha	3
Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe	3
Dolutegravir for second-line treatment: Programmatic implications of new evidence	3
Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice	3
HIV viral load suppression before and after COVID-19 in Kinshasa and Haut Katanga, Democratic Republic of the Congo	3
Antiretroviral therapy under the wing of the COVID-19 epidemic: One look, and different solutions	3
Cervical human papillomavirus prevalence, risk factors and outcomes in a cohort of HIV-infected women in Harare, Zimbabwe	3
Human immunodeficiency virus, diabetes mellitus and thyroid abnormalities: Should we be screening?	3
Utilisation of cervical cancer screening among women living with HIV at Kenya’s national referral hospital	3
Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort	3
Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe	3
Understanding patients reinitiating antiretroviral therapy in two South African districts	3
Sexual risk compensation following voluntary medical male circumcision: Results from a prospective cohort study amongst human immunodeficiency virus-negative adult men in Botswana	3
Continuous quality improvement in HIV and TB services at selected healthcare facilities in South Africa	3
Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid	3
A rapid review and synthesis of the effectiveness of programmes initiating community-based antiretroviral therapy in sub-Saharan Africa	3
A case series of emtricitabine-induced pure red cell aplasia	3
Predictors of low antiretroviral adherence at an urban South African clinic: A mixed-methods study	3
2023 Southern African HIV Clinicians Society Adult Antiretroviral Therapy Guidelines: What’s new?	3